Effect of disease duration on the association between C-reactive protein-albumin ratio and endoscopic activity in ulcerative colitis

• Published in: BMC gastroenterology Vol. 22; no. 1; p. 39
• Main Authors: Furukawa, Shinya, Yagi, Sen, Shiraishi, Kana, Miyake, Teruki, Tange, Kazuhiro, Hashimoto, Yu, Kitahata, Shogo, Kawamura, Tomoe, Ninomiya, Tomoyuki, Mori, Kenichirou, Suzuki, Seiyuu, Shibata, Naozumi, Murakami, Hidehiro, Ohashi, Katsuhisa, Hasebe, Aki, Tomida, Hideomi, Yamamoto, Yasunori, Takeshita, Eiji, Ikeda, Yoshio, Hiasa, Yoichi
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.01.2022; BioMed Central; BMC
• Subjects: Albumin; Analysis; Biomarkers; Body mass index; C-Reactive Protein; Care and treatment; Clinical remission; Colitis, Ulcerative; CRP/albumin ratio; Diagnosis; Endoscopy; Gastroenterology; Gastrointestinal mucosa; Health aspects; Humans; Inflammatory bowel disease; Inflammatory Bowel Diseases; Measurement; Medical examination; Mucosa; Mucosal healing; Mucous Membrane; Patients; Remission; Remission (Medicine); Risk factors; Ulcerative colitis; Japan; Albumin; Clinical remission; Mucosal healing; CRP/albumin ratio; Ulcerative colitis
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-022-02113-3

A simple serum biomarker for clinical outcome in patients with ulcerative colitis (UC) remains an unmet need. Some studies have shown an association between C-reactive protein (CRP)-albumin ratio (CAR) and prognosis in patients with inflammatory bowel disease (IBD), but evidence regarding the association between CAR and UC remains limited. We evaluated the association between CAR and clinical outcome in Japanese patients with UC. Subjects were 273 Japanese patients with UC. Clinical remission was defined as absence of both abnormally high stool frequency (< 3 per day) and rectal bleeding. Mucosal healing (MH) was defined as Mayo endoscopic subscore (MES) 0. Moderate to severe endoscopic activity was defined as MES 2-3. Subjects were divided according to CAR into tertiles (low, moderate, and high). The proportions of patients with clinical remission, MH, and moderate to severe endoscopic activity were 57.9%, 26.0%, and 37.0%, respectively. High CAR was significantly positively associated with moderate to severe endoscopic activity but not MH or clinical remission after adjustment (adjusted odds ratio [OR] 2.18 [95% confidence interval (CI) (1.11-4.35)], p for trend 0.023), but only in patients with long disease duration (> 7 years) (adjusted OR 2.95 [95% CI (1.06-8.79)], p for trend 0.023). CAR was not associated with clinical remission or MH. CAR may be significantly positively associated with moderate to severe endoscopic activity but not clinical remission or MH in Japanese patients with UC. In patients with long UC duration, CAR might be a useful serum marker for disease activity.